Literature DB >> 19554782

[Spermatic cord sarcomas: current status and report of four cases].

Pedro Carrión López1, Héctor Pastor Navarro, Jesús Martínez Ruiz, José Miguel Giménez Bachs, María José Donate Moreno, Lorenzo Polo Ruiz, José María Pastor Guzmán, Carlos Martínez Sanchiz, Rafael Ruiz Mondéjar, Julio Antonio Virseda Rodríguez.   

Abstract

OBJECTIVE: To study and review spermatic cord sarcomas, including symptoms, diagnosis, and treatment. METHODS/
RESULTS: We review the Spanish and international literature and report 4 new cases: 2 patients with well-differentiated spermatic cord liposarcomas (1 treated by simple tumorectomy), 1 patient with liposarcomatous degeneration of a previously excised atypical lipoma, and 1 patient operated for a malignant retroperitoneal fibrous histiocytoma with subsequent local recurrence in the paratesticular region.
CONCLUSIONS: Spermatic cord sarcomas are rare entities that usually appear as painless paratesticular mass. They are diagnosed by imaging studies (ultrasound, computed tomography, magnetic resonance) and confirmed by histological examination. Spermatic cord sarcomas are treated surgically; the efficacy of adjuvant treatments such as chemotherapy or radiation therapy is still under debate.

Entities:  

Mesh:

Year:  2009        PMID: 19554782

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  3 in total

1.  Management of spermatic cord tumors: a rare urologic malignancy.

Authors:  Dayron Rodríguez; Aria F Olumi
Journal:  Ther Adv Urol       Date:  2012-12

2.  Spermatic cord liposarcoma: organ-sparing surgery.

Authors:  J P Peralta; R Godinho; C Rabaça; M Reis
Journal:  BMJ Case Rep       Date:  2013-06-27

Review 3.  Neoplastic diseases of the spermatic cord: an overview of pathological features, evaluation, and management.

Authors:  Gautam Dagur; Jason Gandhi; Kailash Kapadia; Rafid Inam; Noel L Smith; Gargi Joshi; Sardar Ali Khan
Journal:  Transl Androl Urol       Date:  2017-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.